Inventor
MALATHONG VIENGKHAM
US52 patents
⚠️ This page may combine multiple inventors who share the name “MALATHONG VIENGKHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
39 patentsUS10639284B2May 5, 2020
Immunomodulator compounds
CHEMOCENTRYX INC17 citations94
US9809581B2Nov 7, 2017
Inhibitors of CXCR2
CHEMOCENTRYX INC23 citations94
US11485708B2Nov 1, 2022
Compounds for treatment of PD-L1 diseases
CHEMOCENTRYX INC9 citations86
US11426364B2Aug 30, 2022
Immunomodulator compounds
CHEMOCENTRYX INC10 citations86
US11266643B2Mar 8, 2022
Triaryl compounds for treatment of PD-L1 diseases
CHEMOCENTRYX INC13 citations86
US10562896B2Feb 18, 2020
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC11 citations86
US11059834B2Jul 13, 2021
Macrocyclic immunomodulators
CHEMOCENTRYX INC10 citations85
US10919852B2Feb 16, 2021
Immunomodulator compounds
CHEMOCENTRYX INC15 citations85
US11384079B2Jul 12, 2022
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC5 citations84
US10828285B2Nov 10, 2020
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC5 citations84
US10759807B2Sep 1, 2020
Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC7 citations84
US10683294B2Jun 16, 2020
5-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC8 citations84
US10392405B2Aug 27, 2019
Macrocyclic immunomodulators
CHEMOCENTRYX INC13 citations84
US10370363B2Aug 6, 2019
Inhibitors of CXCR2
CHEMOCENTRYX INC6 citations84
US9750722B2Sep 5, 2017
Diazole amides
CHEMOCENTRYX INC5 citations84
US9328116B2May 3, 2016
Diazole lactams
CHEMOCENTRYX INC4 citations84
US9169248B2Oct 27, 2015
Diazole amides
CHEMOCENTRYX INC6 citations84
US9340509B2May 17, 2016
CCR6 compounds
CHEMOCENTRYX INC4 citations82
US11708326B2Jul 25, 2023
Immunomodulator compounds
CHEMOCENTRYX INC4 citations74
US11691985B2Jul 4, 2023
Macrocyclic immunomodulators
CHEMOCENTRYX INC4 citations74
US11485737B2Nov 1, 2022
Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC2 citations73
US11479553B2Oct 25, 2022
5-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC3 citations73
US11478460B2Oct 25, 2022
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC3 citations73
US11434230B2Sep 6, 2022
2-oxindole compounds
CHEMOCENTRYX INC1 citations73
US11040960B2Jun 22, 2021
Inhibitors of CXCR2
CHEMOCENTRYX INC3 citations73
US10759789B2Sep 1, 2020
2-oxindole compounds
CHEMOCENTRYX INC2 citations73
US10744118B2Aug 18, 2020
Diazole lactams
CHEMOCENTRYX INC2 citations73
US10421748B2Sep 24, 2019
2-oxindole compounds
CHEMOCENTRYX INC3 citations73
US9795599B2Oct 24, 2017
CCR6 compounds
CHEMOCENTRYX INC2 citations72
US12268675B2Apr 8, 2025
Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
CHEMOCENTRYX INC0 citations63
US11773091B2Oct 3, 2023
6-5 fused rings as C5a inhibitors
CHEMOCENTRYX INC0 citations63
US12533354B2Jan 27, 2026
Triaryl compounds for treatment of PD-L1 diseases
CHEMOCENTRYX INC0 citations62
US12139475B2Nov 12, 2024
2-oxindole compounds
CHEMOCENTRYX INC0 citations62
US11945805B2Apr 2, 2024
Inhibitors of CXCR2
CHEMOCENTRYX INC0 citations62
US11793771B2Oct 24, 2023
Immunomodulator compounds
CHEMOCENTRYX INC0 citations62
US11759454B2Sep 19, 2023
Diazole lactams
CHEMOCENTRYX INC0 citations62
US10117865B2Nov 6, 2018
CCR6 compounds
CHEMOCENTRYX INC1 citations62
US11872217B2Jan 16, 2024
Indanes as PD-L1 inhibitors
CHEMOCENTRYX INC0 citations52
US10342781B2Jul 9, 2019
Diazole amides
CHEMOCENTRYX INC0 citations52
THERAVANCE INC
8 patentsUS7456199B2Nov 25, 2008
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC49 citations96
US7687519B2Mar 30, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7659403B2Feb 9, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7632847B2Dec 15, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations93
US7569588B2Aug 4, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC34 citations93
US7858795B2Dec 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC14 citations84
US8377966B2Feb 19, 2013
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC0 citations52
US7858792B2Dec 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC0 citations52
MU YONGQI
2 patentsAXT SABINE
1 patentShowing the top 50 of 52 patents by PatentIndex Score.